During the first quarter of 2015, start-up companies raised a total of $2.74 billion, the third quarter in a row in which the record has been broken. (Last quarter’s total was $1.46 billion.) Biopharma companies pulled in an impressive $2.32 billion, half resulting from public start-up fundraising (PIPEs, IPOs, follow-ons). Medical device firms raised $72.5 million (77% from an IPO), and in vitro diagnostics companies combined for $350.4 million, nearly one-third also the result of a start-up going public. (See Exhibit 1.)
Exhibit 1